Veradigm Completes Strategic Alternatives Review and Announces Operational Assessment
Veradigm® (OTCMKTS: MDRX), a prominent provider of healthcare data and technology solutions, has concluded its previously announced strategic alternatives review, aimed at maximizing stockholder value. The company’s Board of Directors (the “Board”) has decided to move forward with its current operational strategies after considering various strategic opportunities.
“We believe Veradigm remains well-positioned to capitalize on the significant market opportunity ahead of us,” said Tom Langan, Interim Chief Executive Officer. “Our leadership team has been actively developing the best path forward for our employees, clients, and stockholders.”
Review of Strategic Alternatives
As part of the review process, the Board, working alongside financial and legal advisors, explored several strategic options, including the possibility of selling the company. After the May 2024 public announcement of the review, Veradigm engaged in discussions with over 30 potential parties and entered into confidentiality agreements with them. The company’s efforts to explore these options led to engagement with both strategic partners and financial sponsors.
Despite discussions and outreach, the process did not result in any final binding proposals. Five bidders submitted non-binding preliminary indications of interest, but no definitive offers were made.
“The Board initiated the review of strategic alternatives with the core goal of maximizing stockholder value,” stated Greg Garrison, Chairman of the Board. “After engaging with over 30 potential parties, the Board has unanimously decided to end the strategic review. However, we remain open to any opportunities that may enhance stockholder value.”
In emphasizing transparency, Mr. Garrison added, “It was crucial for Veradigm to share the outcome of the strategic review with our investors, employees, customers, and partners. We are focused on finalizing the restatement of Veradigm’s 2022 financial statements, becoming current in our financial reporting, and relisting our common stock. Our leadership team is also committed to executing our standalone strategy and delivering comprehensive solutions that empower clients and enhance provider relationships.”
Go-Forward Plan
As part of its forward-looking strategy, Veradigm has brought in an independent strategic advisory firm to assist in refining the company’s long-term plan. The goal of this advisory partnership is to identify operational improvements, boost organizational alignment, and establish strategies for sustained profitable growth.
This move reflects Veradigm’s dedication to positioning itself for long-term success, with a firm commitment to generating value for stockholders. The company’s approach, characterized by its robust network, large scale, and deep expertise, positions it as a market leader in providing end-to-end solutions that empower healthcare clients and foster stronger provider relationships.

We remain confident in Veradigm’s potential to seize the vast opportunities ahead,” Mr. Langan affirmed. “Our leadership team is determined to ensure that our future strategies are aligned with the interests of our employees, clients, and stockholders, helping to drive growth and deliver value.
Financial and Business Update
Looking ahead, Veradigm is set to provide updated financial estimates for the fiscal year 2023, along with preliminary projections for the fiscal year 2024, in mid-March 2025. This update will include an overview of business developments and an audit update. In conjunction with this update, Veradigm will hold a conference call and webcast to provide further details to investors.
Following the March investor update, Veradigm plans to return to a regular cadence of providing updates to the investment community, including offering financial guidance and insights into business performance.
“We greatly appreciate the continued support of our employees, customers, partners, and investors,” said Mr. Langan. “As we move forward, our focus remains on executing our strategy, with the goal of delivering maximum value for all of our stakeholders.”
Veradigm’s commitment to its long-term strategy and operational improvements is a clear indication of its confidence in its market position and its ongoing efforts to create value for its stakeholders. Through transparency, innovation, and strategic planning, the company aims to navigate future opportunities and challenges while ensuring growth and profitability in the evolving healthcare landscape.